Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env

Microbes and Infection

Volumn 7, Issue 14, 2005, Pages 1392-1399

  Ensoli, Barbara ^a   Cafaro, Aurelio ^a   Caputo, Antonella ^b   Fiorelli, Valeria ^a   Ensoli, Fabrizio ^a   Gavioli, Riccardo ^c   Ferrantelli, Flavia ^a   Cara, Andrea ^a   Titti, Fausto ^a   Magnani, Mauro ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF URBINO   (Italy)

Author keywords

HIV AIDS vaccine; Tat protein; V2 Env protein

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

CLINICAL TRIAL; DRUG DESIGN; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 27844474248     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.07.016     Document Type: Short Survey

References (18)

1. A. Cafaro, A. Caputo, C. Fracasso, M.T. Maggiorella, D. Goletti, S. Baroncelli, M. Pace, L. Sernicola, M.L. Koanga-Mogtomo, M. Betti, A. Borsetti, R. Belli, L. Åkerblom, F. Corrias, S. Buttò, J. Heeney, P. Verani, F. Titti, and B. Ensoli Control of SHIV89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine Nat. Med. 5 1999 643 650
2. A. Cafaro, A. Caputo, M.T. Maggiorella, S. Baroncelli, C. Fracasso, M. Pace, A. Borsetti, L. Sernicola, D.R.M. Negri, P. Ten Haaft, M. Betti, Z. Michelini, I. Macchia, E. Fanales-Belasio, R. Belli, F. Corrias, S. Buttò, P. Verani, F. Titti, and B. Ensoli SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine J. Med. Primatol. 29 2000 193 208
3. A. Cafaro, F. Titti, C. Fracasso, M.T. Maggiorella, S. Baroncelli, A. Caputo, D. Goletti, A. Borsetti, M. Pace, E. Fanales-Belasio, B. Ridolfi, D.R.M. Negri, and L. Sernicola R. Belli R., F. Corrias, I. Macchia, P. Leone, Z. Michelini, P. ten Haaft, S. Buttò, P. Verani, B. Ensoli, Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) Vaccine 19 2001 2862 2877
4. M.T. Maggiorella, S. Baroncelli, Z. Michelini, E. Fanales-Belasio, S. Moretti, L. Sernicola, A. Cara, D.R.M. Negri, S. Buttò, V. Fiorelli, A. Tripiciano, A. Scoglio, A. Caputo, A. Borsetti, B. Ridolfi, R. Bona, P. ten Haaft, I. Macchia, P. Leone, M.R. Pavone-Cossut, F. Nappi, M. Ciccozzi, J. Heeney, F. Titti, A. Cafaro, and B. Ensoli Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys Vaccine 22 2004 3258 3269
5. G. Rezza, V. Fiorelli, M. Dorrucci, M. Ciccozzi, A. Tripiciano, A. Scoglio, B. Collacchi, M. Ruiz-Alvarez, C. Giannetto, A. Caputo, L. Tomasoni, E. Castelli, M. Sciandra, A. Sinicco, F. Ensoli, S. Buttò, and B. Ensoli The presence of anti-Tat Ab is predictive of long-term non-progression to AIDS or severe immunodeficiency: findings from a cohort of HIV seroconverters J. Infect. Dis. 191 2005 1321 1324
6. S. Buttò, V. Fiorelli, A. Tripiciano, M.J. Ruiz-Alvarez, A. Scoglio, F. Ensoli, M. Ciccozzi, B. Collacchi, M. Sabbatucci, A. Cafaro, C.A. Guzmán, A. Borsetti, A. Caputo, E. Vardas, M. Colvin, M. Lukwyia, G. Rezza, and B. Ensoli the Tat Multicentric Study Group, Sequence conservation and antibody cross-recognition of the clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italian, Ugandan and South Africans J. Infect. Dis. 188 2003 1171 1180
7. S.W. Barnett, I.K. Srivastava, J.B. Ulmer, J.J. Donnelly, and R. Rappuoli Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 subtypes B and C Microbes Infect. 2005 (in press)
8. G. Barillari, L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R.C. Gallo, and B. Ensoli Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis J. Immunol. 149 1992 3727 3734
9. B. Ensoli, L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R.A. Morgan, P. Wingfield, and R.C. Gallo Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J. Virol. 67 1993 277 287
10. H.C. Chang, F. Samaniego, B.C. Nair, L. Buonaguro, and B. Ensoli HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region AIDS 11 1997 1421 1431
11. C. Perez, I. Albert, K. DeFay, N. Zachariades, L. Gooding, and M. Kriegler A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact Cell 63 1990 251 258
12. C. Jassoy, T. Harrer, T. Rosenthal, B.A. Navia, J. Worth, R.P. Johnson, and B.D. Walker Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens J. Virol. 67 1993 2844 2852
13. A. Ratner, and W.R. Clark Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis J. Immunol. 150 1993 4303 4314
14. K. Ando, K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL J. Immunol. 158 1997 5283 5291
15. P. Ten Haaft, B. Verstrepen, K. Uberla, B. Rosenwirth, and J. Heeney A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques J. Virol. 72 1998 10281 10285
16. A. Cara J. Vargas Jr., M. Keller, S. Jones, A. Mosoian, A. Gurtman, A. Cohen, V. Parkas, F. Wallach, E. Chusid, I.H. Gelman, M.E. Klotman, Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA Virology 292 2002 1 5
17. A. Cara, M.T. Maggiorella, R. Bona, L. Sernicola, S. Baroncelli, D.R.M. Negri, P. Leone, Z. Fagrouch, J. Heeney, F. Titti, A. Cafaro, and B. Ensoli Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA Virology 324 2004 531 539
18. B. Ensoli, and A. Cafaro Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus AIDS Clin. Rev. 2000-2001 23 61